PROPANC BIOPHARMA, INC. Long-term Debt, Gross
PROPANC BIOPHARMA, INC. (PPCB) had Long-term Debt, Gross of $399.24 thousand as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2025-05-15
- 2025-03-31: Long-term Debt, Gross $399.24K.
- 2024-12-31: Long-term Debt, Gross $338.32K.
- 2024-09-30: Long-term Debt, Gross $334.63K.
- 2024-06-30: Long-term Debt, Gross $313.55K.
| Period end | Long-term Debt, Gross | Long-term Debt, Gross as first filed |
|---|---|---|
| 2025-03-31 | $399.24K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $338.32K 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $334.63K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $313.55K 10-Q · filed 2025-05-15 | |
| 2024-03-31 | $432.54K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $544.30K 10-Q · filed 2024-02-20 | |
| 2023-09-30 | $331.50K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $338.36K 10-K · filed 2024-09-30 | |
| 2023-03-31 | $473.36K 10-Q · filed 2023-05-15 | |
| 2022-09-30 | $697.28K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $644.98K 10-K · filed 2023-09-28 | |
| 2022-03-31 | $715.03K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $640.28K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $377.78K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $400.13K 10-K · filed 2022-09-28 | |
| 2021-03-31 | $610.35K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $710.18K 10-Q · filed 2021-02-12 | |
| 2020-09-30 | $594.56K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $1.03M 10-K · filed 2021-09-28 | |
| 2020-03-31 | $1.85M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $2.02M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $1.91M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.08M 10-K · filed 2020-10-01 | |
| 2019-03-31 | $1.18M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $1.67M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $2.30M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $3.10M 10-K · filed 2019-10-15 | |
| 2018-03-31 | $3.13M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $3.19M 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $3.65M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.86M 10-K · filed 2018-09-17 | |
| 2017-03-31 | $2.53M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $100.00K 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $4.35M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $1.72M 10-K · filed 2017-09-28 | $4.35M 10-K · filed 2016-09-28 |
| 2016-03-31 | $4.35M 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |